Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britton Trabert

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|May 4, 2012
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?Britton Trabert, Nicolas Wentzensen, Hannah P Yang, et al.
Cancer Causes & Control : CCC|May 13, 2015
Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health StudyAshley S Felix, Hannah Arem, Britton Trabert, et al.
Fertility and Sterility|September 10, 2013
Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohortBritton Trabert, Emmet J Lamb, Bert Scoccia, et al.
Environmental Health Perspectives|April 29, 2010
Non-dioxin-like polychlorinated biphenyls and risk of endometriosisBritton Trabert, Anneclaire J De Roos, Stephen M Schwartz, et al.
Journal of the National Cancer Institute|January 12, 2018
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer RiskSteven C Moore, Mary C Playdon, Joshua N Sampson, et al.
Journal of the National Cancer Institute|January 4, 2026
Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED studyZeni Wu, Aika Wojt, Britton Trabert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 5, 2014
Long-term relationship of ovulation-stimulating drugs to breast cancer riskLouise A Brinton, Bert Scoccia, Kamran S Moghissi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2021
Common Analgesic Use for Menstrual Pain and Ovarian Cancer RiskNaoko Sasamoto, Ana Babic, Allison F Vitonis, et al.
Steroids|January 28, 2019
Estrogen metabolism pathways in preeclampsia and normal pregnancyDavid E Cantonwine, Thomas F McElrath, Britton Trabert, et al.
Journal of the National Cancer Institute|December 14, 2022
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US womenAndrea Romanos-Nanclares, Fred K Tabung, Jennifer A Sinnott, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|May 4, 2012
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?Britton Trabert, Nicolas Wentzensen, Hannah P Yang, et al.
Cancer Causes & Control : CCC|May 13, 2015
Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health StudyAshley S Felix, Hannah Arem, Britton Trabert, et al.
Fertility and Sterility|September 10, 2013
Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohortBritton Trabert, Emmet J Lamb, Bert Scoccia, et al.
Environmental Health Perspectives|April 29, 2010
Non-dioxin-like polychlorinated biphenyls and risk of endometriosisBritton Trabert, Anneclaire J De Roos, Stephen M Schwartz, et al.
Journal of the National Cancer Institute|January 12, 2018
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer RiskSteven C Moore, Mary C Playdon, Joshua N Sampson, et al.
Journal of the National Cancer Institute|January 4, 2026
Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED studyZeni Wu, Aika Wojt, Britton Trabert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 5, 2014
Long-term relationship of ovulation-stimulating drugs to breast cancer riskLouise A Brinton, Bert Scoccia, Kamran S Moghissi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 10, 2021
Common Analgesic Use for Menstrual Pain and Ovarian Cancer RiskNaoko Sasamoto, Ana Babic, Allison F Vitonis, et al.
Steroids|January 28, 2019
Estrogen metabolism pathways in preeclampsia and normal pregnancyDavid E Cantonwine, Thomas F McElrath, Britton Trabert, et al.
Journal of the National Cancer Institute|December 14, 2022
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US womenAndrea Romanos-Nanclares, Fred K Tabung, Jennifer A Sinnott, et al.
Pageof 19